Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Subscribe To Our Newsletter & Stay Updated
